GOSS Gossamer Bio Inc
Company Analysis
Latest News
🟢 Gossamer Bio is trading 5.4% up today after H.C. Wainwright raised its target to $90
Gossamer Bio is trading 5.4% up at $11.89 after continued investor reaction to H.C. Wainwright maintaining a Buy rating and raising its price target from $2 to...
🟢 Gossamer Bio is trading 9.23% up today as U.S. markets open higher
Gossamer Bio is trading 9.23% up at $11.72 as U.S. markets open higher. - The S&P 500 is up 0.65%. - The Nasdaq Composite is up 0.85%. - No company-specific...
🟢 Gossamer Bio is trading 12.21% up in pre-market as major U.S. indices gain over 0.5%
Gossamer Bio is trading 12.21% up at $12.04 as broader risk-on sentiment lifts major U.S. indices. - The S&P 500, Nasdaq Composite, and Dow Jones were all...
🟢 Gossamer Bio is trading 5.4% up in pre-market amid broader risk-on sentiment
Gossamer Bio is trading 5.41% up at $11.31 amid broader risk-on sentiment; no new company-specific announcement was identified for September 21, 2026. - The...
🟢 Gossamer Bio is trading 7.27% up today in after-hours trading despite no new company-specific announcement
Gossamer Bio is trading 7.27% up in after-hours trading at $11.51 after closing September 18, 2026, at $10.73, with no new company-specific announcement dated...
🔴 Gossamer Bio is trading 9.4% down today after recent rally
Gossamer Bio is trading at $10.81 (-9.42%), likely reflecting profit-taking after its recent rally. • Shares gained 8.94% on September 17 and 5.59% on...
🟢 Gossamer Bio is trading 10.04% up today amid biotech-sector strength
Gossamer Bio is trading at $12.06, up 10.04%, as biotech stocks rally. - The biotech sector is up 2.55%, alongside stronger major indexes. - No clear...
🟢 Gossamer Bio is trading 8.6% up today as biotech stocks rally
Gossamer Bio is trading at $11.72, up 8.57%, as biotech-sector strength and a broader risk-on market rebound support the move. - No fresh company-specific...
🟢 Gossamer Bio is trading 7% up today with no clear company-specific catalyst identified
Gossamer Bio is trading 6.89% up at $11.10, with no clearly reported company-specific catalyst identified for September 16, 2026. - The 1-for-80 reverse stock...
🔴 Gossamer Bio falls 5.4% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🔴 Gossamer Bio is trading 5.3% down today amid continued volatility following its 1-for-80 reverse stock split
Gossamer Bio is trading at $10.16 (5.3% down) as the stock experiences ongoing volatility following its 1-for-80 reverse stock split. • The reverse split...
🔴 Gossamer Bio is trading 5.55% down today after a 1-for-80 reverse stock split
Gossamer Bio is trading at $10.76, down 5.55%, after its 1-for-80 reverse stock split became effective at 11:59 p.m. ET on September 10, 2026. - Every 80...
Gossamer Bio Effects 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance
Gossamer Bio, Inc. has implemented a 1-for-80 reverse stock split of its common stock, which became effective at 11:59 p.m. ET on September 10, 2026. The...
Gossamer Bio's 1-for-80 Reverse Split Keeps Nasdaq Hopes Alive, but Can a Shrinking Biotech Survive on $57 Million and One Drug?
Shares plunged 10.5% to $0.14 on September 10 as Gossamer Bio executed one of the most aggressive reverse stock splits in recent biotech memory — an 80-to-1...
🔴 Gossamer Bio is trading 11% down today after board selected 1-for-80 reverse split
Gossamer Bio is trading 10.52% down now at $0.14 after its board selected a 1-for-80 reverse stock split to regain compliance with Nasdaq’s minimum bid-price...
🔴 Gossamer Bio is trading 6% down in pre-market after board selected a 1-for-80 reverse split
Gossamer Bio is trading 6.01% down now at $0.15 after its board selected a 1-for-80 reverse stock split to regain compliance with Nasdaq’s minimum bid-price...
Gossamer Bio triggers 1-for-80 reverse split, aiming for Nasdaq compliance
Gossamer Bio’s board of directors approved a 1-for-80 reverse stock split of its common stock. The company intends to increase its per-share trading price to...
🔴 Gossamer Bio is trading 16.34% down today — cause remains unclear
Gossamer Bio is trading 16.34% down at $0.15, based on the provided live-market price; no clear company-specific catalyst has been identified for September 9,...
🔴 Gossamer Bio is trading 18% down in pre-market — No clear company-specific catalyst identified
Gossamer Bio is trading 18% down at $0.15, with no clear company-specific catalyst emerging for September 9, 2026. - Scheduled to present at the Cantor Global...
🔴 Gossamer Bio is trading 5.04% down today amid dilution concerns from its August 21 placement
Gossamer Bio is trading 5.04% down now at $0.16, with investor concerns focused on financing-related dilution despite broader biotechnology and major U.S....